{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:33:16Z","timestamp":1791469996116,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T00:00:00Z","timestamp":1355788800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms2295","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T04:50:06Z","timestamp":1355806206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":202,"title":["Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex"],"prefix":"10.1038","volume":"3","author":[{"given":"Atsushi","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okio","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,18]]},"reference":[{"key":"BFncomms2295_CR1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0140-6736(06)69041-7","volume":"368","author":"G Baird","year":"2006","unstructured":"Baird G. et al. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 368, 210\u2013215 (2006).","journal-title":"Lancet"},{"key":"BFncomms2295_CR2","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. text revision. ( American Psychiatric Association: Washington DC,, (2000)."},{"key":"BFncomms2295_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11065-008-9076-8","volume":"412","author":"F Happ\u00e9","year":"2008","unstructured":"Happ\u00e9 F. & Ronald A. The \u2018fractionable autism triad\u2019: a review of evidence from behavioural, genetic, cognitive and neural research. Neuropsychol. Rev. 412, 287\u2013304 (2008).","journal-title":"Neuropsychol. Rev."},{"key":"BFncomms2295_CR4","doi-asserted-by":"publisher","first-page":"55R","DOI":"10.1203\/PDR.0b013e318212ec6e","volume":"69","author":"JN Constantino","year":"2011","unstructured":"Constantino J. N. The quantitative nature of autistic social impairment. Pediatr. Res. 69, 55R\u201362R (2011).","journal-title":"Pediatr. Res."},{"key":"BFncomms2295_CR5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/archpediatrics.2009.98","volume":"163","author":"RE Rosenberg","year":"2009","unstructured":"Rosenberg R. E. et al. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch. Pediatr. Adolesc. Med. 163, 907\u2013914 (2009).","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"BFncomms2295_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1469-8749.2009.03523.x","volume":"52","author":"AO Caglayan","year":"2010","unstructured":"Caglayan A. O. Genetic causes of syndromic and non-syndromic autism. Dev. Med. Child Neurol. 52, 130\u2013138 (2010).","journal-title":"Dev. Med. Child Neurol."},{"key":"BFncomms2295_CR7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09146","volume":"466","author":"D Pinto","year":"2010","unstructured":"Pinto D. et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466, 368\u2013372 (2010).","journal-title":"Nature"},{"key":"BFncomms2295_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrg2346","volume":"9","author":"BS Abrahams","year":"2008","unstructured":"Abrahams B. S. & Geschwind D. H. Advances in autism genetics: on the threshold of a new neurobiology. Nat. Rev. Genet. 9, 341\u2013355 (2008).","journal-title":"Nat. Rev. Genet."},{"key":"BFncomms2295_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1172\/JCI32483","volume":"118","author":"DJ Posey","year":"2008","unstructured":"Posey D. J., Stigler K. A., Erickson C. A. & McDougle C. J. Antipsychotics in the treatment of autism. J. Clin. Invest. 118, 6\u201314 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFncomms2295_CR10","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M van Slegtenhorst","year":"1997","unstructured":"van Slegtenhorst M. et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277, 805\u2013808 (1997).","journal-title":"Science"},{"key":"BFncomms2295_CR11","doi-asserted-by":"crossref","unstructured":"European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75, 1305\u20131315 (1993).","DOI":"10.1016\/0092-8674(93)90618-Z"},{"key":"BFncomms2295_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/088307389801301206","volume":"13","author":"ES Roach","year":"1998","unstructured":"Roach E. S., Gomez M. R. & Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J. Child Neurol. 13, 624\u2013628 (1998).","journal-title":"J. Child Neurol."},{"key":"BFncomms2295_CR13","doi-asserted-by":"publisher","first-page":"R251","DOI":"10.1093\/hmg\/ddi260","volume":"14","author":"DJ Kwiatkowski","year":"2005","unstructured":"Kwiatkowski D. J. & Manning B. D. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum. Mol. Genet. 14, (Spec. No. 2) R251\u2013R258 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFncomms2295_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.molmed.2010.10.002","volume":"17","author":"D Ehninger","year":"2011","unstructured":"Ehninger D. & Silva A. J. Rapamycin for treating tuberous sclerosis and autism spectrum disorders. Trends Mol. Med. 17, 78\u201387 (2011).","journal-title":"Trends Mol. Med."},{"key":"BFncomms2295_CR15","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awf124","volume":"125","author":"PF Bolton","year":"2002","unstructured":"Bolton P. F., Park R. J., Higgins J. N. P., Griffiths P. D. & Pickles A. (2002) Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain 125, 1247\u20131255.","journal-title":"Brain"},{"key":"BFncomms2295_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/jmg.2003.012757","volume":"41","author":"JC Lewis","year":"2004","unstructured":"Lewis J. C., Thomas H. V., Murphy K. C. & Sampson J. R. Genotype and psychological phenotype in tuberous sclerosis. J. Med. Genet. 41, 203\u2013207 (2004).","journal-title":"J. Med. Genet."},{"key":"BFncomms2295_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00787-006-0570-3","volume":"16","author":"PJ de Vries","year":"2007","unstructured":"de Vries P. J., Hunt A. & Bolton P. F. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. Eur. Child Adolesc. Psychiatry 16, 16\u201324 (2007).","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"BFncomms2295_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1212\/WNL.0b013e3182104347","volume":"76","author":"AL Numis","year":"2011","unstructured":"Numis A. L. et al. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology 76, 981\u2013987 (2011).","journal-title":"Neurology"},{"key":"BFncomms2295_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.molmed.2007.06.003","volume":"13","author":"PJ de Vries","year":"2007","unstructured":"de Vries P. J. & Howe C. J. The tuberous sclerosis complex proteins - a GRIPP on cognition and neurodevelopment. Trends Mol. Med. 13, 319\u2013326 (2007).","journal-title":"Trends Mol. Med."},{"key":"BFncomms2295_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.nurt.2010.05.001","volume":"7","author":"PJ de Vries","year":"2010","unstructured":"de Vries P. J. Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex. Neurotherapeutics 7, 275\u2013282 (2010).","journal-title":"Neurotherapeutics"},{"key":"BFncomms2295_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(97)80012-8","volume":"349","author":"PF Bolton","year":"1997","unstructured":"Bolton P. F. & Griffiths P. D. Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet 349, 392\u2013395 (1997).","journal-title":"Lancet"},{"key":"BFncomms2295_CR22","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1177\/08830738020170111401","volume":"17","author":"NC Walz","year":"2002","unstructured":"Walz N. C., Byars A. W., Egelhoff J. C. & Franz D. N. Supratentorial tuber location and autism in tuberous sclerosis complex. J. Child Neurol. 17, 830\u2013832 (2002).","journal-title":"J. Child Neurol."},{"key":"BFncomms2295_CR23","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1073\/pnas.151033798","volume":"98","author":"T Kobayashi","year":"2001","unstructured":"Kobayashi T. et al. A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc. Natl Acad. Sci. USA 98, 8762\u20138767 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms2295_CR24","first-page":"1206","volume":"59","author":"T Kobayashi","year":"1999","unstructured":"Kobayashi T. et al. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res. 59, 1206\u20131211 (1999).","journal-title":"Cancer Res."},{"key":"BFncomms2295_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI7319","volume":"104","author":"H Onda","year":"1999","unstructured":"Onda H., Lueck A., Marks P. W., Warren H. B. & Kwiatkowski D. J. Tsc2+\/\u2212 mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J. Clin. Invest. 104, 687\u2013695 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFncomms2295_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ng0195-70","volume":"9","author":"T Kobayashi","year":"1995","unstructured":"Kobayashi T., Hirayama Y., Kobayashi E., Kubo Y. & Hino O. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat. Genet. 9, 70\u201374 (1995).","journal-title":"Nat. Genet."},{"key":"BFncomms2295_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ana.21317","volume":"62","author":"SM Goorden","year":"2007","unstructured":"Goorden S. M., van Woerden G. M., van der Weerd L., Cheadle J. P. & Elgersma Y. Cognitive deficits in Tsc1+\/\u2212 mice in the absence of cerebral lesions and seizures. Ann. Neurol. 62, 648\u2013655 (2007).","journal-title":"Ann. Neurol."},{"key":"BFncomms2295_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/jnen\/59.3.188","volume":"59","author":"M Mizuguchi","year":"2000","unstructured":"Mizuguchi M. et al. Novel cerebral lesions in the Eker rat model of tuberous sclerosis: cortical tuber and anaplastic ganglioglioma. J. Neuropathol. Exp. Neurol. 59, 188\u2013196 (2000).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFncomms2295_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1788","volume":"14","author":"D Ehninger","year":"2008","unstructured":"Ehninger D. et al. Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis. Nat. Med. 14, 843\u2013848 (2008).","journal-title":"Nat. Med."},{"key":"BFncomms2295_CR30","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s10519-010-9399-0","volume":"41","author":"R Waltereit","year":"2011","unstructured":"Waltereit R., Japs B., Schneider M., de Vries P. J. & Bartsch D. Epilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in rats. Behav. Genet. 41, 364\u2013372 (2011).","journal-title":"Behav. Genet."},{"key":"BFncomms2295_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/mp.2010.115","volume":"17","author":"D Ehninger","year":"2012","unstructured":"Ehninger D. et al. Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice. Mol. Psychiatry 17, 62\u201370 (2012).","journal-title":"Mol. Psychiatry"},{"key":"BFncomms2295_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora S. L. et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am. J. Hum. Genet. 68, 64\u201380 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"BFncomms2295_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/hmg\/ddq491","volume":"20","author":"LH Zeng","year":"2011","unstructured":"Zeng L. H. et al. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum. Mol. Genet. 20, 445\u2013454 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"BFncomms2295_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1083\/jcb.jcb.200206108","volume":"159","author":"A Jaeschke","year":"2002","unstructured":"Jaeschke A. et al. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J. Cell Biol. 159, 217\u2013224 (2002).","journal-title":"J. Cell Biol."},{"key":"BFncomms2295_CR35","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki K., Li Y., Zhu T., Wu J. & Guan K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648\u2013657 (2002).","journal-title":"Nat. Cell Biol."},{"key":"BFncomms2295_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"BD Manning","year":"2002","unstructured":"Manning B. D., Tee A. R., Logsdon M. N., Blenis J. & Cantley L. C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Mol. Cell 10, 151\u2013162 (2002).","journal-title":"Mol. Cell"},{"key":"BFncomms2295_CR37","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nrn2851","volume":"11","author":"JL Silverman","year":"2010","unstructured":"Silverman J. L., Yang M., Lord C. & Crawley J. N. Behavioural phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 11, 490\u2013502 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFncomms2295_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbr.2005.11.004","volume":"168","author":"YS Mineur","year":"2006","unstructured":"Mineur Y. S., Huynh L. X. & Crusio W. E. Social behavior deficits in the Fmr1 mutant mouse. Behav. Brain Res. 168, 172\u2013175 (2006).","journal-title":"Behav. Brain Res."},{"key":"BFncomms2295_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1037\/0735-7044.122.2.293","volume":"122","author":"CH McNaughton","year":"2008","unstructured":"McNaughton C. H. et al. Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome. Behav. Neurosci. 122, 293\u2013300 (2008).","journal-title":"Behav. Neurosci."},{"key":"BFncomms2295_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.brainres.2003.12.013","volume":"1002","author":"ES Brodkin","year":"2004","unstructured":"Brodkin E. S., Hagemann A., Nemetski S. M. & Silver L. M. Social approach-avoidance behavior of inbread mouse strains towards DBA\/2 mice. Brain Res. 1002, 151\u2013157 (2004).","journal-title":"Brain Res."},{"key":"BFncomms2295_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1515\/REVNEURO.2006.17.1-2.111","volume":"17","author":"C Lever","year":"2006","unstructured":"Lever C., Burton S. & O'Keefe J. Rearing on hind legs, environmental novelty, and the hippocampal formation. Rev. Neurosci. 17, 111\u2013133 (2006).","journal-title":"Rev. Neurosci."},{"key":"BFncomms2295_CR42","doi-asserted-by":"publisher","first-page":"e15500","DOI":"10.1371\/journal.pone.0015500","volume":"5","author":"T Umeda","year":"2010","unstructured":"Umeda T. et al. Evaluation of Pax6 mutant rat as a model for autism. PLoS One 5, e15500 (2010).","journal-title":"PLoS One"},{"key":"BFncomms2295_CR43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbr.2009.11.031","volume":"208","author":"BC Ryan","year":"2010","unstructured":"Ryan B. C., Young N. B., Crawley J. N., Bodfish J. W. & Moy S. S. Social deficits, stereotypy and early emergence of repetitive behavior in the C58\/J inbred mouse strain. Behav. Brain Res. 208, 178\u2013188 (2010).","journal-title":"Behav. Brain Res."},{"key":"BFncomms2295_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/neuro.08.008.2007","volume":"1","author":"V Brinks","year":"2007","unstructured":"Brinks V., van der Mark M., de Kloet R. & Oitzl M. Emotion and cognition in high and low stress sensitive mouse strains: a combined neuroendocrine and behavioral study in BALB\/c and C57BL\/6J mice. Front. Behav. Neurosci. 1, 8 (2007).","journal-title":"Front. Behav. Neurosci."},{"key":"BFncomms2295_CR45","doi-asserted-by":"publisher","first-page":"e9706","DOI":"10.1371\/journal.pone.0009706","volume":"5","author":"MA Mines","year":"2010","unstructured":"Mines M. A., Yuskaitis C. J., King M. K., Beurel E. & Jope R. S. GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. PLoS One 5, e9706 (2010).","journal-title":"PLoS One"},{"key":"BFncomms2295_CR46","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1523\/JNEUROSCI.5074-07.2008","volume":"28","author":"K Sakurai","year":"2008","unstructured":"Sakurai K. & Osumi N. The neurogenesis-controlling factor, Pax6, inhibits proliferation and promotes maturation in murine astrocytes. J Neurosci. 28, 4604\u20134612 (2008).","journal-title":"J Neurosci."},{"key":"BFncomms2295_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.neuron.2006.03.023","volume":"50","author":"CH Kwon","year":"2006","unstructured":"Kwon C. H. et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 50, 377\u2013388 (2006).","journal-title":"Neuron"},{"key":"BFncomms2295_CR48","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1523\/JNEUROSCI.5685-08.2009","volume":"29","author":"J Zhou","year":"2009","unstructured":"Zhou J. et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J. Neurosci. 29, 1773\u20131783 (2009).","journal-title":"J. Neurosci."},{"key":"BFncomms2295_CR49","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","volume":"363","author":"DA Krueger","year":"2010","unstructured":"Krueger D. A. et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N. Engl. J. Med. 363, 1801\u20131811 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms2295_CR50","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","volume":"17","author":"DM Davies","year":"2011","unstructured":"Davies D. M. et al. Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin. Cancer Res. 17, 4071\u20134081 (2011).","journal-title":"Clin. Cancer Res."},{"key":"BFncomms2295_CR51","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","volume":"15","author":"W Li","year":"2005","unstructured":"Li W. et al. The HMG-CoA reductase inhibitor lovastatin reverse the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr. Biol. 15, 1961\u20131967 (2005).","journal-title":"Curr. Biol."},{"key":"BFncomms2295_CR52","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1073\/pnas.0503224102","volume":"102","author":"CM Johannessen","year":"2005","unstructured":"Johannessen C. M. et al. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc. Natl Acad. Sci. USA 102, 8573\u20138578 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms2295_CR53","doi-asserted-by":"publisher","first-page":"7106","DOI":"10.1158\/0008-5472.CAN-06-4798","volume":"67","author":"L Ma","year":"2007","unstructured":"Ma L. et al. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. Cancer Res. 67, 7106\u20137112 (2007).","journal-title":"Cancer Res."},{"key":"BFncomms2295_CR54","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.neuropharm.2008.09.017","volume":"56","author":"WW Min","year":"2009","unstructured":"Min W. W. et al. Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential. Neuropharmacology 56, 463\u2013472 (2009).","journal-title":"Neuropharmacology"},{"key":"BFncomms2295_CR55","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1523\/JNEUROSCI.3696-09.2010","volume":"30","author":"A Sharma","year":"2010","unstructured":"Sharma A. et al. Dysregulation of mTOR signaling in fragile X syndrome. J. Neurosci. 30, 694\u2013702 (2010).","journal-title":"J. Neurosci."},{"key":"BFncomms2295_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature10658","volume":"480","author":"BD Auerbach","year":"2011","unstructured":"Auerbach B. D., Osterweil E. K. & Bear M. F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63\u201368 (2011).","journal-title":"Nature"},{"key":"BFncomms2295_CR57","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","volume":"56","author":"G Dolen","year":"2007","unstructured":"Dolen G. et al. Correction of fragile X syndrome in mice. Neuron 56, 955\u2013962 (2007).","journal-title":"Neuron"},{"key":"BFncomms2295_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1006\/hbeh.1997.1382","volume":"31","author":"JN Crawley","year":"1997","unstructured":"Crawley J. N. & Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm. Behav 31, 197\u2013211 (1997).","journal-title":"Horm. Behav"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncomms2295","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncomms2295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms2295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T19:19:40Z","timestamp":1672946380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms2295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,18]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1]]}},"alternative-id":["BFncomms2295"],"URL":"https:\/\/doi.org\/10.1038\/ncomms2295","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,18]]},"assertion":[{"value":"14 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1292"}}